Problems of erythropoietin in the protective study of cerebral ischemic injury
10.3760/cma.j.issn.1673-4165.2012.10.012
- VernacularTitle:红细胞生成素在脑缺血损伤保护研究中存在的问题
- Author:
Xiaomeng LIU
;
Ping LIU
;
Yumin LUO
- Publication Type:Journal Article
- Keywords:
Erythropoietin;
Brain Ischemia;
Neuroprotective Agents
- From:
International Journal of Cerebrovascular Diseases
2012;(10):782-786
- CountryChina
- Language:Chinese
-
Abstract:
Erythropoietin (EPO) belongs to cytokines.It mainly promotes erythropoiesis in the peripheral blood circulation.Fundamental research shows that EPO can reduce cerebral ischemic injury through a variety of mechanisms,but at the same time,there are many unsolved problems.In addition,the two clinical trial outcomes are also very inconsistent.This article reviews the problems in EPO research.
